ENDONOVO THERAPEUTICS
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Its platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its second platform is the development of non-invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases.
ENDONOVO THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Woodland Hills, California, United States
Country:
United States
Website Url:
http://www.endonovo.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Dianthus Therapeutics
Dianthus Therapeutics is a biotech company developer of therapeutics and drugs.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Reactive Medical Labs
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-07-11 | Rio Grande Neurosciences | Rio Grande Neurosciences acquired by Endonovo Therapeutics | 30 M USD |
Official Site Inspections
http://www.endonovo.com
- Host name: gator4013.hostgator.com
- IP address: 192.185.17.113
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Endonovo Therapeutics"
Endonovo Therapeutics - Crunchbase Company Profile & Funding
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Its platform, Cell Free Therapeutics, โฆSee details»
Endonovo Therapeutics โ Management
Prior to his appointment as Endonovoโs President and Chief Commerical Officer of its Medical Division, Mr. Weisberg served as CEO and President of Amherst Pharmaceuticals, CEO of โฆSee details»
About Endonovo - SofPulse
In 2008 Mr. Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics, Inc,. and led the company to become listed on the OTCBB in 2012. From โฆSee details»
Endonovo Therapeutics, Inc. | LinkedIn
Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronicsโข platform is a โฆSee details»
Endonovo Therapeutics, Inc. (ENDV) - Yahoo Finance
Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Corporate Governance Endonovo Therapeutics, Inc.โs ISS Governance QualityScore as of โฆSee details»
Endonovo Closes Asset Purchase Agreement for a Minimum of โฆ
With completion of the APA, both Endonovo and SofPulse, Inc. share a strategic vision and a commitment for long term growth. Finalized Terms of SofPulse, Inc. Spi. Los Angeles, CA, โฆSee details»
Endonovo Therapeutics โ Contact
Endonovo Therapeutics, Inc. 6320 Canoga Avenue, 15th Floor Woodland Hills, CA 91367 Phone: 1+800-701-1223 Fax: 1+818-230-9899 Email: [email protected]See details»
Endonovo Announces Plans for Spin-off of Medical IP and Assets
Dec 15, 2022 Endonovo intends to apply a portion of the shares available through the spin-off to satisfy its present debt holders. While no firm arrangements have been made, Endonovo โฆSee details»
Endonovo Therapeutics Details Plan to Spin Off Medical Device โฆ
Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current medical device division, โฆSee details»
Endonovo Therapeutics (ENDV) Stock Price, News & Analysis
5 days ago Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The โฆSee details»
ENDV-Investment-site
Endonovo researchers have laid the foundation for ground-breaking advancements in the field of PEMF Technology. Our commitment to protecting intellectual property and ongoing research, โฆSee details»
Endonovo Therapeutics, Inc. (ENDV) - Yahoo Finance Canada
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers โฆSee details»
Endonovo Announces Plans for Spin-off of Medical IP and Assets
Dec 15, 2022 Endonovo intends to apply a portion of the shares available through the spin-off to satisfy its present debt holders. While no firm arrangements have been made, Endonovo โฆSee details»
Endonovo Therapeutics Signs Agreement with NAMSA to Develop โฆ
LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA โ a leading Global Contract โฆSee details»
Endonovo Therapeutics Inc. (ENDV) Announces it has filed a โฆ
Los Angeles, CA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTC-ENDV) an Innovative Medical Devices developer and distributor is pleased to announce it has โฆSee details»
Endonovo Therapeutics, Inc. | Los Angeles CA - Facebook
Endonovo Therapeutics, Inc., Woodland Hills. 331 likes · 2 talking about this. Endonovo Therapeutics is a clinical stage developer of non-invasive Electroceutical devices for the โฆSee details»
Endonovo Announces Plans for Spin-off of Medical IP and Assets
Dec 15, 2022 New Company To Be Formed for SofPulse® Medical Device Line Los Angeles, CA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) โฆSee details»
Why Endonovo Therapeutics Holds Plenty Of Upside Potential For ...
Alan, CEO of Endonovo informed me that they believe the same mechanism that stimulated bone regeneration in rabbits and also expanded neuronal and blood stem cells to therapeutic levels โฆSee details»
Endonovo Therapeutics, Inc. (ENDV) - Yahoo Finance
Get the latest Endonovo Therapeutics, Inc. (ENDV) stock news and headlines to help you in your trading and investing decisions.See details»